Arrivent Biopharma shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Arrivent Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Arrivent Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arrivent Biopharma by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $258k | 14k | 18.45 |
| 2025-03-31 | $302k | 16k | 18.49 |
| 2024-12-31 | $418k | 16k | 26.64 |
| 2024-09-30 | $293k | 12k | 23.50 |
| 2024-06-30 | $82k | 4.4k | 18.55 |
| 2024-03-31 | $224k | 13k | 17.86 |